Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician
- 31 May 2004
- journal article
- research article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 31 (2) , 331-352
- https://doi.org/10.1016/j.ucl.2004.01.001
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Combined Analysis of Two Multicenter, Randomized, Placebo-Controlled Studies of Pamidronate Disodium for the Palliation of Bone Pain in Men With Metastatic Prostate CancerJournal of Clinical Oncology, 2003
- Side effects of androgen deprivation therapy: monitoring and minimizing toxicityUrology, 2003
- The potential role of bisphosphonates in prostate cancerProstate Cancer and Prostatic Diseases, 2002
- A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate CarcinomaJNCI Journal of the National Cancer Institute, 2002
- Hormone Therapy for Locally Advanced Prostate CancerJournal of Urology, 2002
- Prostate cancer trends in the era of prostate-specific antigenUrologic Clinics of North America, 2002
- Background to and Management of Treatment-Related Bone Loss in Prostate CancerDrugs & Aging, 2002
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997